Media Newsroom of

Syngene International Limited


Syngene International Limited is one of Asia’s largest Contract Research Organizations. It provides discovery and developmental services for new molecular entities across multiple platforms including Small Molecules, Large Molecules, Antibody-Drug Conjugates and Oligonucleotides. These services are aimed towards bringing novel molecules to the market by supporting the R&D efforts of organizations across diverse sectors like pharma, biotechnology, nutrition and animal health. Syngene offers an integrated platform for R&D focussed organizations to optimize their R&D investments and develop their novel molecules with a distinctive cost advantage. In FY2015, Syngene serviced 221 clients including 8 of the top 10 global pharma companies. For more details, visit:

Syngene appoints Jonathan Hunt as CEO-designate

PRESS RELEASESyngene appoints Jonathan Hunt as CEO-designateJanuary 04, 2016, Bengaluru, IndiaSyngene International Limited, one of Asia’s largest Contract Research Organizations, today announced the appointment of Jonathan Hunt as CEO-designate. Mr Hunt will take charge as CEO post the retirement of…


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login